1. Home
  2. HALO vs FIVE Comparison

HALO vs FIVE Comparison

Compare HALO & FIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • FIVE
  • Stock Information
  • Founded
  • HALO 1998
  • FIVE 2002
  • Country
  • HALO United States
  • FIVE United States
  • Employees
  • HALO N/A
  • FIVE N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • FIVE Department/Specialty Retail Stores
  • Sector
  • HALO Health Care
  • FIVE Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • FIVE Nasdaq
  • Market Cap
  • HALO 7.4B
  • FIVE 7.1B
  • IPO Year
  • HALO N/A
  • FIVE 2012
  • Fundamental
  • Price
  • HALO $59.97
  • FIVE $136.52
  • Analyst Decision
  • HALO Buy
  • FIVE Buy
  • Analyst Count
  • HALO 8
  • FIVE 17
  • Target Price
  • HALO $65.63
  • FIVE $122.88
  • AVG Volume (30 Days)
  • HALO 1.3M
  • FIVE 1.2M
  • Earning Date
  • HALO 08-05-2025
  • FIVE 08-27-2025
  • Dividend Yield
  • HALO N/A
  • FIVE N/A
  • EPS Growth
  • HALO 55.40
  • FIVE N/A
  • EPS
  • HALO 3.76
  • FIVE 4.78
  • Revenue
  • HALO $1,084,306,000.00
  • FIVE $4,035,191,000.00
  • Revenue This Year
  • HALO $25.48
  • FIVE $16.16
  • Revenue Next Year
  • HALO $19.78
  • FIVE $10.06
  • P/E Ratio
  • HALO $15.95
  • FIVE $29.05
  • Revenue Growth
  • HALO 25.64
  • FIVE 10.71
  • 52 Week Low
  • HALO $42.01
  • FIVE $52.38
  • 52 Week High
  • HALO $70.51
  • FIVE $143.88
  • Technical
  • Relative Strength Index (RSI)
  • HALO 64.61
  • FIVE 56.08
  • Support Level
  • HALO $57.68
  • FIVE $136.51
  • Resistance Level
  • HALO $59.38
  • FIVE $143.88
  • Average True Range (ATR)
  • HALO 1.32
  • FIVE 4.32
  • MACD
  • HALO 0.26
  • FIVE -0.65
  • Stochastic Oscillator
  • HALO 70.87
  • FIVE 54.03

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About FIVE Five Below Inc.

Five Below Inc is a specialty value retailer offering merchandise targeted at the tween and teen demographic. The Company's edited assortment of products includes select brands and licensed merchandise. It derives revenue from sales of the Company's merchandise to customers.

Share on Social Networks: